Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 4,728,000 | 2,883,000 | 4,537,000 | 4,127,000 | 4,661,000 |
| Cost of Goods | 1,709,000 | 69,000 | 1,654,000 | 1,466,000 | 1,502,000 |
| Gross Profit | 3,019,000 | 2,814,000 | 2,883,000 | 2,661,000 | 3,159,000 |
| Operating Expenses | 1,887,000 | 2,189,000 | 1,831,000 | 1,935,000 | 1,872,000 |
| Operating Income | 1,132,000 | 625,000 | 1,052,000 | 726,000 | 1,287,000 |
| Other Income | 31,000 | 56,000 | -937,000 | -2,000 | -59,000 |
| Pre-tax Income | 1,163,000 | 681,000 | 115,000 | 724,000 | 1,228,000 |
| Income Tax | 316,000 | 96,000 | -252,000 | 209,000 | 333,000 |
| Net Income Continuous | 792,000 | 399,000 | 339,000 | 479,000 | 842,000 |
| Net Income Discontinuous | N/A | 46,000 | 18,000 | N/A | 14,000 |
| Net Income | $792,000 | $445,000 | $357,000 | $479,000 | $856,000 |
| EPS Basic Total Ops | 0.41 | 0.23 | 0.19 | 0.25 | 0.44 |
| EPS Basic Continuous Ops | 0.41 | 0.21 | 0.18 | 0.25 | 0.43 |
| EPS Basic Discontinuous Ops | N/A | 0.02 | 0.01 | N/A | 0.01 |
| EPS Diluted Total Ops | 0.41 | 0.23 | 0.18 | 0.25 | 0.44 |
| EPS Diluted Continuous Ops | 0.41 | 0.21 | 0.17 | 0.25 | 0.43 |
| EPS Diluted Discontinuous Ops | N/A | 0.02 | 0.01 | N/A | 0.01 |
| EBITDA(a) | $1,310,000 | $811,000 | $1,240,000 | $908,000 | $1,466,000 |